I caught up Noel earlier in the year to find out how ##CRB coped with 2020 and the impact of the pandemic, how 2021 was looking and his thoughts in terms of trends for 2021 and beyond.
A really wide ranging conversation touching on a lot of different topics relating to #LifeScience
Interview breakdown
Overview of SlateXpace and Noels background. 1:23
2020 in a word, and why? 2:39
Were they able to achieve their objectives in 2020? 3:50
When did they start planning for the Pandemic 5:12
How did the pandemic impact SlateXpace, and their sector, and what did they do to minimise the impact? 7:50
What have been the main positives for 2020? Personally, Professionally and for the Industry 9:35
Key learnings from 2020 and what would they have done differently 12:15
What does Noel see as the new normal being. 15:50
Key trends in 2021.18:30
What’s are SlateXpace plans for 2021 and beyond? 22.39
Message for those watching this 24:25
You can find out more about SlateXpace and CRB by visiting;
On LinkedIn
https://lnkd.in/eZkM56y
https://lnkd.in/ebbeKeh
Websites/Links:
www.crbgroup.com
www.slatexpace.com
You can watch Noel's previous #ChatsWithChaudhrey on CRB's #CellandGenherapy report here;
https://lnkd.in/ebbC2mx, AND view this and many more interviews and demos from many other industry experts across Pharma, Bio-Pharma and Life Science on my YouTube channel RSK Life Science Media https://www.youtube.com/channel/UC9vdET2xLlGweqveW6JmQdQ
#PharmaFacilities, #CDMO, #FacilitiesOfTheFuture, #ATMP, #COVID19, #LifeSciences, #GeneTherapy, #CellTherapy,